Compare HLF & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLF | PSNL |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | United States | United States |
| Employees | 8500 | N/A |
| Industry | Other Pharmaceuticals | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | 2004 | 2019 |
| Metric | HLF | PSNL |
|---|---|---|
| Price | $11.88 | $11.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $18.00 | $12.20 |
| AVG Volume (30 Days) | 1.7M | ★ 5.6M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $5,037,500,000.00 | $69,648,000.00 |
| Revenue This Year | $4.97 | $15.34 |
| Revenue Next Year | $3.80 | $41.46 |
| P/E Ratio | $20.70 | ★ N/A |
| Revenue Growth | ★ 0.89 | N/A |
| 52 Week Low | $7.56 | $3.84 |
| 52 Week High | $20.40 | $16.39 |
| Indicator | HLF | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 41.67 | 43.14 |
| Support Level | $11.39 | $6.39 |
| Resistance Level | $13.41 | $12.53 |
| Average True Range (ATR) | 0.50 | 1.17 |
| MACD | -0.09 | -0.50 |
| Stochastic Oscillator | 10.81 | 1.23 |
Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.